Get the Stockscreener App
2.79
24.34%
0.51
After Hours:
2.75
-0.04
-1.43%
Seastar Medical Holding Corp stock is traded at $2.79, with a volume of 571.07K.
It is up +24.34% in the last 24 hours and up +3.47% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
See More
Previous Close:
$2.28
Open:
$2.38
24h Volume:
571.07K
Relative Volume:
5.05
Market Cap:
$10.60M
Revenue:
$881.00K
Net Income/Loss:
$-13.67M
P/E Ratio:
-0.2557
EPS:
-10.9133
Net Cash Flow:
$-14.20M
1W Performance:
+24.89%
1M Performance:
+3.47%
6M Performance:
-52.92%
1Y Performance:
-88.33%
1-Day Range:
$2.38
$3.14
1-Week Range:
$2.07
$3.14
52-Week Range:
$2.07
$25.10
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Compare ICU vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
2.79 | 8.66M | 881.00K | -13.67M | -14.20M | -10.91 |
VRTX
Vertex Pharmaceuticals Inc
|
453.76 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.40 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
693.89 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Seastar Medical Holding Corp Stock (ICU) Latest News
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Gains Report: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year2026 Trade Ideas & AI Based Buy and Sell Signals - baoquankhu1.vn
SeaStar Medical Holding Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: SeaStar Medical’s Q4 2025 revenue soars, stock edges up - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SeaStar Medical Holding 2025 10-K: Revenue $1.234M, EPS $(5.86) - TradingView
SeaStar Medical (NASDAQ: ICU) details QUELIMMUNE launch and pivotal AKI trial - Stock Titan
SEASTAR MEDICAL HOLDING ($ICU) Releases Q4 2025 Earnings - Quiver Quantitative
SeaStar Medical reports $1.2M revenue for 2025, narrows annual loss to $12.2M - TradingView
[8-K] SeaStar Medical Holding Corp Reports Ma... - Stock Titan
13 more children's hospitals adopt SeaStar therapy as AKI trial tops 50% - Stock Titan
SeaStar Medical Holding Corp expected to post a loss of $1.06 a shareEarnings Preview - TradingView
If You Invested $1,000 in SeaStar Medical Holding Corp (ICU) - Stock Titan
ICU Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Catalysts: Can SeaStar Medical Holding Corporation continue delivering strong returnsSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
EV Market: Can SeaStar Medical Holding Corporation be the next market leaderQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
SeaStar Medical Highlights SCD Platform, QUELIMMUNE Growth and NEUTRALIZE-AKI Timeline at Forum - Defense World
Insider Buy: Will SeaStar Medical Holding Corporation stock recover after earnings2026 Top Decliners & Accurate Technical Buy Alerts - baoquankhu1.vn
SeaStar Medical (ICU) Expected to Announce Earnings on Thursday - Defense World
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 - ChartMill
After-hours results: SeaStar Medical sets March 25 webcast - Stock Titan
OTC Markets Hosts Virtual Investor Presentation with Eric Schlorff, CEO of SeaStar Medical, and David Bautz, PhD, Senior Analyst at Zacks SCR - Yahoo Finance
Trend Report: How does SeaStar Medical Holding Corporation compare to its peers2026 Buyback Activity & AI Forecast Swing Trade Picks - baoquankhu1.vn
ICU Stock Price, Quote & Chart | SEASTAR MEDICAL HOLDING CORP (NASDAQ:ICU) - ChartMill
Signal Recap: Does SeaStar Medical Holding Corporation offer margin of safetyTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
B2i Digital Highlights Life Sciences Virtual Investor Forum as a Featured Conference - TradingView
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - The Manila Times
SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th - The Manila Times
SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI - ChartMill
Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Rises By 85.5% - Defense World
SeaStar Medical (NASDAQ:ICU) vs. Organon & Co. (NYSE:OGN) Financial Contrast - Defense World
Is SeaStar Medical Holding Corporation likely to announce a buybackQuarterly Trade Report & Stepwise Trade Signal Guides - mfd.ru
ICU Should I Buy - Intellectia AI
Aug Weekly: Will SeaStar Medical Holding Corporation stock recover after earningsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
ICU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
What are SeaStar Medical Holding Corporation’s earnings expectationsGap Up & AI Forecasted Entry/Exit Points - mfd.ru
SeaStar Medical Holding Co. (NASDAQ:ICUCW) Short Interest Down 12.5% in January - Defense World
How SeaStar Medical Holding Corporation Equity Warrant stock trades before earnings2025 Big Picture & Weekly Momentum Stock Picks - mfd.ru
Can SeaStar Medical Holding Corporation Equity Warrant stock reach $100 price target2025 Buyback Activity & Safe Investment Capital Preservation Plans - mfd.ru
Investors report 9.99% SeaStar Medical (ICU) ownership via warrants - Stock Titan
SeaStar Medical price target lowered to $6 from $10 at Maxim - TipRanks
ICU: Publication Validates Real-World Clinical Impact of QUELIMMUNE in Pediatric AKI - Smartkarma
ICU News Today | Why did SeaStar Medical stock go up today? $ICU - MarketBeat
Published on: 2026-02-11 10:56:42 - mfd.ru
Director Kenneth Van Heel awarded 3,000 RSUs at SeaStar Medical (ICU) - Stock Titan
SeaStar Medical reports strong survival data for QUELIMMUNE therapy By Investing.com - Investing.com Australia
SeaStar Medical stock falls after publishing pediatric therapy data By Investing.com - Investing.com Nigeria
SeaStar Medical stock falls after publishing pediatric therapy data - Investing.com Australia
SeaStar Medical reports ‘strong’ survival data in Quelimmune study - TipRanks
SeaStar Medical reports strong survival data for QUELIMMUNE therapy - Investing.com
SeaStar Medical Reports Positive 90-Day Survival Data for QUELIMMUNE Therapy in Pediatric Patients with Acute Kidney Injury - Quiver Quantitative
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seastar Medical Holding Corp Stock (ICU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
| Van Heel Kenneth | Director |
Aug 26 '25 |
Buy |
0.89 |
25,000 |
22,248 |
39,400 |
| Van Heel Kenneth | Director |
Aug 27 '25 |
Buy |
0.86 |
10,000 |
8,565 |
49,400 |
| Chung Kevin | Chief Medical Officer |
Aug 22 '25 |
Buy |
0.80 |
10,000 |
8,000 |
58,184 |
| Neuman John | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
88,000 |
| Vincent Bernadette N | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
8,000 |
| Van Heel Kenneth | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
10,400 |
| Chung Kevin | Chief Medical Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
48,184 |
| Schlorff Eric | Chief Executive Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
21,667 |
0 |
98,517 |
| Baird Jennifer A | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
18,000 |
0.02%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):